Cargando…
Design and analysis of umbrella trials: Where do we stand?
BACKGROUND: The efficiencies that master protocol designs can bring to modern drug development have seen their increased utilization in oncology. Growing interest has also resulted in their consideration in non-oncology settings. Umbrella trials are one class of master protocol design that evaluates...
Autores principales: | Ouma, Luke O., Wason, James M. S., Zheng, Haiyan, Wilson, Nina, Grayling, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9596938/ https://www.ncbi.nlm.nih.gov/pubmed/36313987 http://dx.doi.org/10.3389/fmed.2022.1037439 |
Ejemplares similares
-
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods
por: Ouma, Luke Ondijo, et al.
Publicado: (2021) -
Bayesian modelling strategies for borrowing of information in randomised basket trials
por: Ouma, Luke O., et al.
Publicado: (2022) -
Clinical chorioamnionitis: where do we stand now?
por: Lukanović, David, et al.
Publicado: (2023) -
Artificial Intelligence Applications in Dermatology: Where Do We Stand?
por: Gomolin, Arieh, et al.
Publicado: (2020) -
Assessment of Liver Function With MRI: Where Do We Stand?
por: Río Bártulos, Carolina, et al.
Publicado: (2022)